Christina joined Brandon Capital in 2021.
Christina is part of the CUREator team, supporting the translation of early-stage biomedical innovations.
Prior to joining CUREator, Christina was an Investment Analyst at Brandon Capital and a research and project lead at the University of Queensland, where she led drug discovery and development programs. She was awarded a Researcher Exchange and Development within Industry (REDI) Fellowship through the Medical Research Future Fund (MRFF), enabling hands-on industry experience embedded within the Brandon Capital team.
At the Institute for Molecular Bioscience (IMB), University of Queensland, Christina worked alongside Protagonist Therapeutics Pty Ltd (NASDAQ:PTGX), gaining exposure to commercially driven research and industry-aligned translational development pathways. Christina has also supported multiple early-stage life science start-up companies through advisory and translational support roles.
Christina holds a Bachelor of Biotechnology (Honours) and a PhD in Medicinal Chemistry from The University of Queensland.
